ANIXA BIOSCIENCES INC EPS - Earnings per Share 2010-2022 | ANIX

ANIXA BIOSCIENCES INC eps - earnings per share from 2010 to 2022. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
ANIXA BIOSCIENCES INC Annual EPS
2021 $-0.45
2020 $-0.45
2019 $-0.59
2018 $-0.79
2017 $-0.58
2016 $-0.57
2015 $-0.16
2014 $-1.10
2013 $-1.25
2012 $-0.50
2011 $-1.00
2010 $-0.75
2009 $-3.00
ANIXA BIOSCIENCES INC Quarterly EPS
2022-01-31 $-0.13
2021-10-31 $-0.14
2021-07-31 $-0.14
2021-04-30 $-0.08
2021-01-31 $-0.09
2020-10-31 $-0.09
2020-07-31 $-0.11
2020-04-30 $-0.12
2020-01-31 $-0.13
2019-10-31 $-0.10
2019-07-31 $-0.11
2019-04-30 $-0.13
2019-01-31 $-0.25
2018-10-31 $-0.30
2018-07-31 $-0.30
2018-04-30 $-0.08
2018-01-31 $-0.11
2017-10-31 $-0.07
2017-07-31 $-0.12
2017-04-30 $0.02
2017-01-31 $-0.41
2016-10-31 $-0.11
2016-07-31 $-0.13
2016-04-30 $-0.15
2016-01-31 $-0.18
2015-10-31 $-0.13
2015-07-31 $-0.18
2015-04-30 $-0.26
2015-01-31 $0.41
2014-10-31 $-0.14
2014-07-31 $0.04
2014-04-30 $-0.50
2014-01-31 $-0.50
2013-10-31 $-0.50
2013-07-31 $-0.25
2013-04-30 $-0.25
2013-01-31 $-0.25
2012-10-31 $0.00
2012-07-31 $0.00
2012-04-30 $0.00
2012-01-31 $0.00
2011-10-31 $-0.25
2011-07-31 $-0.25
2011-04-30 $-0.25
2011-01-31 $-0.25
2010-10-31 $0.00
2010-07-31 $-0.25
2010-04-30 $-0.25
2010-01-31 $-0.25
2009-10-31 $-2.25
2009-07-31 $-0.25
2009-04-30 $-0.25
2009-01-31 $-0.25
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.101B $0.001B
Anixa Biosciences, Inc. operates as a bio-technology company. It develops diagnostics and therapeutics to detect cancer. Anixa Biosciences Inc., formerly known as ITUS Corporation, is based in San Jose, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $161.724B 9.84
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.093B 15.93
Biohaven Pharmaceutical Holding (BHVN) United States $9.948B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.434B 0.00
Emergent Biosolutions (EBS) United States $1.592B 6.82
Arcus Biosciences (RCUS) United States $1.327B 33.64
Myovant Sciences (MYOV) United Kingdom $0.961B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.483B 0.00
Gelesis Holdings (GLS) United States $0.357B 0.00
Zymeworks (ZYME) Canada $0.336B 0.00
Ambrx Biopharma (AMAM) United States $0.154B 0.00
Enzo Biochem (ENZ) United States $0.117B 24.00
SQZ Biotechnologies (SQZ) United States $0.092B 0.00